![Page 1: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/1.jpg)
©ALL RIGHTS RESERVED - Confidential 1
Scott PrydeBravoSolution UK
From Data Aggregation to Improved Financial & Clinical Outcomes... What is possible now?
![Page 2: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/2.jpg)
©ALL RIGHTS RESERVED - Confidential 2
Alignment, Governance & Information
# Field Safety Notices
![Page 3: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/3.jpg)
©ALL RIGHTS RESERVED - Confidential 3
Reimbursement, Cost & Revenue Leakage
![Page 4: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/4.jpg)
©ALL RIGHTS RESERVED - Confidential 4
Underpinning Savings Initiatives
![Page 5: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/5.jpg)
©ALL RIGHTS RESERVED - Confidential 5
Hospital Spend Data Quality
NB One exception: Typically where there is a significant peak in Building and Construction works, the data quality drops to very low in that category as data on major works is almost always held on a separate construction system
![Page 6: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/6.jpg)
©ALL RIGHTS RESERVED - Confidential 6
Misleading Data
![Page 7: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/7.jpg)
©ALL RIGHTS RESERVED - Confidential 7
MPN Overlap & Variety by Trust
# of Organisations
% O
verla
p
% Common SKU by No. Of Trusts
![Page 8: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/8.jpg)
©ALL RIGHTS RESERVED - Confidential 8
Catalogue Ref: 157004070 - C-STEM AMT SIZE1 STD OFFSET - EACHeClass: Medical Prosthesis – Joint Replacement HipsBenchmark: Medical Devices - Orthopaedic – Primary – Hip - Stem – Uncemented
What’s in a number ?
[C1 (8004) 12345699999 157004070 (19) 9999999 (21) 99999999
(Asset Identifier)(Organisation ID )(ProductCode)(Lot No.) XX(Serial No.)XXX
What’s not ?
![Page 9: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/9.jpg)
©ALL RIGHTS RESERVED - Confidential 9
Aggregation & Classification
![Page 10: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/10.jpg)
©ALL RIGHTS RESERVED - Confidential 10
Price Benchmarking
![Page 11: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/11.jpg)
©ALL RIGHTS RESERVED - Confidential 11
Evidence Tracking
![Page 12: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/12.jpg)
©ALL RIGHTS RESERVED - Confidential 12
Other Medical category examples ...
Trauma Nail Demand Volatility / Time
![Page 13: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/13.jpg)
©ALL RIGHTS RESERVED - Confidential 13
Opportunity Analysis & Guidance
Spend £557,160
% Savings Value Complexity
A 57% £320,000 10
Aggressive brand repositioning to lower price high evidence cemented products e.g. Lubinus SPII, National Regional collaborative bulk commitment and surgeon led negotiation, Manage Consignments directly
B 52% £291,000 9
Alignment with National lowest price clinical policy and brand usage, Significant shift from uncemented to cemented products. Cllaborative, surgeon led negotiation and bulk commitment to maximise leverage
C 27% £150,000 6
Alignment with National average price aligning with technology indicator averages and brand choices. Collaborative, surgeon led negotiation and bulk commitment to maximise leverage
D 17% £96,000 3 Consolidate current brand usage and surgeon led commercial negotiationE 13% £70,000 1 Ceramic on Ceramic - reduce to national average.F -18% -£100,000 0 Uncontroled brand usage & supply base fragmentation
![Page 14: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/14.jpg)
©ALL RIGHTS RESERVED - Confidential 14
Shared Market Intelligence
![Page 15: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/15.jpg)
©ALL RIGHTS RESERVED - Confidential 15
Summary
• Investing in data aggregation is essential alongside improving systems & standards
• Data aggregation, analysis & information sharing is possible now
• Improved financial and clinical outcomes will follow
• BUT ..... information is a compass not a silver bullet ... delivery competency will still be required to achieve value
• Co-operate to share market, technology , strategy expertise & knowledge across the system
![Page 16: From Health Spend Data to Improved Financial & Clinical Outcomes](https://reader036.vdocuments.mx/reader036/viewer/2022062501/568bd8581a28ab2034a30297/html5/thumbnails/16.jpg)
©ALL RIGHTS RESERVED - Confidential 16
Executive Briefings
Hospital Benchmarking & Analytics
Understanding GS1 & Data Aggregation
Outcome led Contract Management
MedTech Market Analysis
Inventory, Demand & Utilisation Analytics
Clinical Commissioning Group Spend Analysis
CCG Non-Medical Auctions & Strategies
Scott PrydeBravoSolution UK